Learn More
Medchemexpress LLC 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide | 287403-39-8 | 99.6% | 398.50 g/mol | C17H22N2O5S2 | 50 MG

Supplier: Medchemexpress LLC HY10144850MG
TMI-1 (WAY-171318) is a small-molecule research tool that potently inhibits TNF-α converting enzyme (TACE/ADAM17) and multiple matrix metalloproteinases, induces apoptosis via caspase-dependent pathways, and has demonstrated activity in cell-based assays and animal models of inflammation and cancer.
- Potent TACE inhibition (reported IC50 ≈ 8.4 nM)
- Induces apoptosis in cancer cell lines via caspase-dependent mechanisms
- Reduces TNF-α secretion and alleviates inflammatory symptoms in animal models
- Available as solid and solution forms for in vitro and in vivo use
- High purity suitable for research applications
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.